TY  - GEN
AU  - Ruano, David
AU  - López-Martín, José A
AU  - Moreno, Lucas
AU  - Lassaletta, Álvaro
AU  - Bautista, Francisco
AU  - Andión, Maitane
AU  - Hernández, Carmen
AU  - González-Murillo, África
AU  - Melen, Gustavo
AU  - Alemany, Ramón
AU  - Madero, Luis
AU  - Garcia-Castro, Javier
AU  - Ramírez, Manuel
PY  - 2020
DO  - 10.1016/j.ymthe.2020.01.019
UR  - http://hdl.handle.net/20.500.12105/14957
AB  - We present here the results of a first-in-human, first-in-child trial for patients with relapsed/refractory solid tumors using Celyvir, an advanced therapy medicine that combines autologous mesenchymal stem cells (MSCs) carrying an oncolytic...
LA  - eng
PB  - Cell Press
KW  - Clinical trial
KW  - Mesenchymal stem cells
KW  - Oncolytic virotherapy
KW  - Pediatric tumor
KW  - Adolescent
KW  - Adult
KW  - Age Factors
KW  - Aged
KW  - Child
KW  - Child, Preschool
KW  - Dependovirus
KW  - Feasibility Studies
KW  - Humans
KW  - Mesenchymal Stem Cell Transplantation
KW  - Mesenchymal Stem Cells
KW  - Middle Aged
KW  - Neoplasms
KW  - Oncolytic Viruses
KW  - Transplantation, Autologous
KW  - Treatment Outcome
TI  - First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors
TY  - research article
ER  -